- May 27, 2024‘750,000 deaths can be prevented’: Alarm on toll of bacteria resistant to antibiotics
In conversation with The Telegraph, OHT’s Dr. Ramanan Laxminarayan, who has been monitoring antimicrobial resistance (AMR) trends for nearly two decades, discussed the findings of a series on AMR published in The Lancet. “We performed a novel analysis of how big the burden of AMR is for children under age five and adults over age […]
Read moreRead more Read More
- May 27, 2024Over 750,000 antimicrobial resistance deaths preventable yearly via vaccines, water, sanitation and infection control
In the Medical Xpress, “Co-author Professor Ramanan Laxminarayan, President of the One Health Trust and Senior Research Scholar at Princeton University, says, ‘Reducing the impact of AMR through pharmaceuticals is not simply a matter of developing new antibiotics. Unless access and affordability are guaranteed, the vast number of deaths from resistant bacterial infections will continue […]
Read moreRead more Read More - May 27, 2024Huge number of deaths linked to superbugs can be avoided, say experts
In The Guardian, The Lancet series on AMR, written by experts brought together by OHT’s Ramanan Laxminarayan, uses novel modeling data that shows that deaths in poorer countries could be cut by 18% – or about 750,000 a year – with preventive measures. “Experts have warned that if the world does not prioritise action on […]
Read moreRead more Read More - May 26, 2024Antibiotic resistance: 750,000 deaths could be avoided every year
Find the coverage of The Lancet series on antimicrobial resistance, a series gathered by OHT’s Dr. Ramanan Laxminarayan in la Repubblica, a news publication in Italy. Read more here.
Read moreRead more Read More - May 24, 2024Urgent global action needed to avert AMR deaths
In Science Africa, “With an estimated 750,000 deaths associated with antimicrobial resistance (AMR), urgent action is needed to prevent further escalation, authors of a new Lancet Series on the issue said.” This series on AMR gathered experts led by OHT’s Dr. Ramanan Laxminarayan. “Access to effective antibiotics is essential to patients worldwide. A failure to […]
Read moreRead more Read More - May 24, 2024Our window of opportunity is shrinking
Find the coverage of The Lancet series on antimicrobial resistance, a series gathered by OHT’s Dr. Ramanan Laxminarayan in Pharmazeutische Zeitung, a news publication in Germany. Read more here.
Read moreRead more Read More - May 24, 2024Antimicrobial resistance must be addressed now, global experts warn
In MedPage Today, “An estimated 750,000 deaths linked to antimicrobial resistance (AMR) could be prevented every year through available vaccines, water and sanitation, and infection control methods, according to a series of four papers in The Lancet opens in a new tab or window on sustainable access to antibiotics. ‘The window of opportunity to ensure […]
Read moreRead more Read More - May 24, 2024Lancet releases new series on AMR, underscores need for action with focus on LMICs
In Down to Earth coverage of the Lancet Series on AMR, One Health Trust’s Dr. Ramanan Laxminarayan said, “The main thing we’re trying to do is reframe this issue as one of sustainable access to effective antibiotics.” “It’s about people having access to antibiotics that really work when they need them. And that requires thinking […]
Read moreRead more Read More - May 15, 2024Vaccine Stockpile could help in tackling bird flu
In Hindustan Time’s Reflections, OHT’s Dr. Ramanan Laxminarayan included his thoughts on the current trajectory of the evolution of the bird flu virus and the urgent need for surveillance, drug stockpiles, and planning for vaccine scaleup. “H5N1 is potentially a far more serious threat than Covid-19. While it is too early to ring the alarm, […]
Read moreRead more Read More
News
One Health Trust’s work and researchers are featured in international media outlets. Find resources to help understand OHT’s work.
